Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy

JAMA. 2023 Sep 19;330(11):1097-1098. doi: 10.1001/jama.2023.12776.

Authors

Romain Jouffroy¹, Renato M Lupinacci², Nathalie Dournon³

Affiliations

¹ Service de Médecine Intensive Réanimation, Hôpital Universitaire Ambroise Paré, Boulogne-Billancourt, France.
² Department of Digestive and Oncologic Surgery, Hôpital Universitaire Ambroise Paré, Boulogne-Billancourt, France.
³ Service de Maladies Infectieuses et Tropicales, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France.

PMID: 37721615
DOI: 10.1001/jama.2023.12776

No abstract available

Publication types

Comparative Study
Letter
Comment

MeSH terms

Anti-Bacterial Agents* / therapeutic use
Antibiotic Prophylaxis*
Cefoxitin* / therapeutic use
Pancreaticoduodenectomy*
Piperacillin, Tazobactam Drug Combination* / therapeutic use

Substances

Cefoxitin
Piperacillin, Tazobactam Drug Combination
Anti-Bacterial Agents